The only approved oral GLP-1 drug is Rybelsus, a pill for type 2 diabetes from Novo Nordisk, the same company that makes semaglutide and sells it as Ozempic and Wegovy
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Multi-receptor agonists that target the glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide 1 (GLP-1) receptors may improve outcomes in type 2 diabetes because this condition is linked to hyperglycemia and obesity
These receptors primarily couple to Gs proteins that stimulate adenylate cyclase, increasing intracellular cyclic AMP concentrations
its about building or maintaining muscle while reducing fat
The workout feels less intimidating and more like something you can actually sustain
Even if your appetite is diminished, try consuming easily digestible foods such as plain crackers, toast, or bananas every 23 hours